MDMA-assisted Therapy for Severe PTSD
MDMA-assisted Cognitive Processing Therapy Versus Cognitive Processing Therapy for Veterans With Severe Posttraumatic Stress Disorder
Recruiting
Phase 2
Interventional Study
PTSD
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Patricia Suppes · Other
Who this trial is looking for
This trial is looking for U.S. military veterans with severe PTSD. Participants will receive either MDMA-assisted therapy or standard therapy for PTSD and will need to attend study visits.
Are You a Good Fit for This Trial?
You may be able to join if
- I am a U.S. Military Veteran
- I am at least 18 years old
- I can read and speak English
- I agree to have study visits recorded
- I have been diagnosed with PTSD for at least 6 months
- I have severe PTSD symptoms in the last month
- I weigh at least 48 kilograms
- I am not pregnant or breastfeeding
You may not be able to join if
- I have a medical condition that makes sympathomimetic drugs harmful
- I have a current unstable medical illness
- I have any cardiac conditions
- I have used ketamine or received ECT in the last 12 weeks
- I have moderate or severe alcohol use disorder in the last 12 months
- I have current serious suicide risk
- I have a personal history of serious mental health disorders
- I lack social support or a stable living situation
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
In partnership with the Veterans Affairs (VA) Palo Alto Health Care System and Stanford University, this study aims to evaluate clinical outcomes, assess implementation feasibility, and health economics of MDMA-assisted Cognitive Processing Therapy (MDMA-aCPT) in the treatment of posttraumatic stress disorder (PTSD). Through a randomized comparison of MDMA-aCPT versus Cognitive Processing Therapy …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants are eligible to be included in the study only if all of the following criteria apply:
1. Are at least 18 years at the time of signing the informed consent
2. Are a U.S Military Veteran
3. Are receiving services from VA Palo Alto Healthcare System, VA San Francisco …
Contacts